Daclahep 60mg Tablet (Daclatasvir)
Daclahep 60mg Tablet (Daclatasvir)

Daclahep 60mg Tablet (Daclatasvir)

prescriptionImage Prescription Required

Manufactured By

Hetero

Pack Of

28

Salt Composition

Daclatasvir

Storage

Keep in cold place

Safe and Secure


Your health and safety are our top priority. All our medicines are sourced from trusted suppliers, thoroughly tested, and approved for use. We follow strict quality control standards to ensure every product is safe, effective, and reliable. You can enquire knowing your wellness is in good hands.

ALL SUBSTITUTES

Dacikast 60mg Tablet

Dacikast 60mg Tablet

Dasicast 60mg Tablet

Dasicast 60mg Tablet

Overview

Daclahep 60mg Tablet (daclatasvir) is an antiviral prescription-based medication that is used in the treatment of chronic hepatitis C virus (HCV) infection. The medicine's active composition is daclatasvir dihydrochloride in a 60mg concentration. It is classified as a Direct-Acting Antiviral (DAA) that works by blocking a viral protein (NS5A) required for the hepatitis C virus to multiply.

This reduces the amount of virus in the body and helps clear the infection over time. Use the medicine exactly as prescribed by the healthcare professional to ensure safe treatment.

Quick Product Facts

FieldPublication wording
Branddaclahep
Generic / Active IngredientDaclatasvir
Strength60
Dosage FormTablet
Manufacturer / MarketerHetero
Pack Size28
Prescription RequiredYes
Therapeutic CategoriesHepatitis Medicines
Useshepatitis

Uses and Indications

Hepatitis C

Side Effects of Daclahep 60mg Tablet

Most of the medicine causes side effects; some are acute and some are mild. Consult the healthcare professional if any of these symptoms persist while using the Daclahep 60mg Tablet (daclatasvir):

● Nausea

● Headache

● Tiredness

● Dizziness

● Decreased heart rate

● Liver failure

● Reactivation of hepatitis B virus​

Daclahep 60mg Tablet Dosage and How To Take It

Daclatasvir 60mg Tablet (Daclahep) should be taken at the fixed time everyday with or without food for better absorption. Always consult a healthcare professional to ensure safe and effective treatment option.

Proper intake may help achieve maximum viral suppression, improve treatment success rate and reduce the risk of drug resistance in patients with hepatitis C.

Safety Advice for Daclahep 60mg Tablet

  • ● Alcohol: Avoid drinking alcohol when using the Daclahep 60mg Tablet, since it will decrease the efficiency of your medication. Alcohol will increase the pressure on your liver and delay your recovery period. To get the best outcome, it would be advisable to refrain from alcohol use when you are under treatment.
  • ● Driving: Daclahep 60mg Tablet (daclatasvir) might lead to drowsiness, dizziness, and lack of alertness in some patients. Therefore, it is recommended not to drive or use any kind of heavy machinery after taking the tablet.
  • ● Pregnancy: Daclatasvir 60mg Tablet (Daclahep) should not be taken during pregnancy because this medication can cause harm to the unborn child, leading to deformities or any other complications. Pregnant women must seek advice from their physician before taking this medicine.
  • ● Breastfeeding: Daclahep 60mg Tablet is not prescribed for breastfeeding women, as the medicine directly passes from the mother's bloodstream into breast milk, which may harm the nursing infant.
  • ● Kidney: For individuals suffering from kidney disorders, it is advisable to seek medical advice before taking the Daclahep 60mg tablet. This is because kidneys play an important role in the metabolism and excretion of the drug.
  • ● Liver: Daclahep 60mg Tablet (Daclatasvir) should not be taken by liver patients, as it can put extra strain on the liver and may worsen liver function.

FAQs About Daclahep 60mg Tablet

1. What is Daclatasvir 60mg Tablet (Daclahep) dosage and duration?

downArrowImg

The dose and length of Daclahep 60 mg Tablet therapy will be determined by your physician depending on your condition, extent of infection, and general state of health. In most cases, it is prescribed for once daily use together with other drugs for a period of 12 to 24 weeks. It is recommended that you follow your doctor’s instructions in order to get safe treatment.

2. Who can use Daclahep 60mg Tablet (daclatasvir)?

downArrowImg

Daclahep 60mg Tablet is used by the patient of chronic hepatitis C infection, exactly as prescribed by the healthcare professional.

3. Can I use Daclahep 60mg Tablet with other combination of treatment?

downArrowImg

Daclahep 60mg Tablet can be used alongside with other treatments, but only under the supervision of a healthcare professional.

4. Is Daclatasvir 60mg Tablet (Daclahep) completely curing the chronic hepatitis C infection?

downArrowImg

The Daclahep 60 mg Tablet can help stop the reproduction of the virus inside the body and alleviate the symptoms in patients. However, this treatment might not give you a permanent solution to your health problems, so take it under a doctor's prescription.

5. What are the side effects of Daclahep 60mg Tablet (daclatasvir)?

downArrowImg

The common side effects of the Daclahep 60mg Tablet are nausea, headache, tiredness, etc. Reach out to the doctor if any of the symptoms persist or worsen.

References

● Reviriego, C. (2011). Daclatasvir dihydrochloride. Drugs of the Future, 36(10).

● Hassib, S. T., Taha, E. A., Elkady, E. F., & Barakat, G. H. (2017). Reversed-phase liquid chromatographic method for determination of daclatasvir dihydrochloride and study of its degradation behavior. Chromatographia, 80(7), 1101-1107.

● Shah, S. H., Nasiri, M. I., Sarwar, H., Ali, A., Naqvi, S. B. S., Anwer, S., & Kashif, M. (2021). RP-HPLC method development and validation for quantification of daclatasvir dihydrochloride and its application to pharmaceutical dosage form. Pak. J. Pharm. Sci, 34(3), 951-956.

● Abdel-Lateef, M. A., Omar, M. A., Ali, R., & Derayea, S. M. (2019). Xanthene based spectroscopic probe for the analysis of HCV antiviral, daclatasvir dihydrochloride, through feasible complexation reaction. Microchemical Journal, 145, 672-675.

● El Azab, N. F., El-Mosallamy, S. S., Mahmoud, A. M., & Trabik, Y. A. (2025). Design of a core-shell molecularly imprinted polymer for highly selective detection of daclatasvir dihydrochloride in tablets and human plasma. Microchemical Journal, 213, 113723.​

Marketer Details

Hetero

Author Details

logoImg

Written By:

Nonish Sharma

I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More


reviewerImg

Reviewed By:

Vaibhav Shakya

Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More

Last Updated: 19 Oct 2026 | 02:31 pm (IST)

Want to know More

Check our Editor Policy

Disclaimer

Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.

Chat on WhatsApp